- Univadis Medical News
- 1 comment
PPI use not linked with dementia, says new study
The new findings contradict findings from a 2016 study from Germany.
Recommended in Pharmacists
- Clinical summaries
- 1 comment
Psoriasis: increased risk for non-melanoma skin cancer with TNF inhibitors
- Univadis Medical News
- no comment
Brain damage reversed in a drowned toddler
- Univadis Medical News
- 1 comment
Views sought on digital innovation in health in the EU
- Clinical summaries
- 1 comment
- FULLTEXT
COPD: efficacy and safety of direct switch to indacaterol/glycopyrronium
- Clinical summaries
- 1 comment
- FULLTEXT
Parkinson's disease: NICE issues updated recommendations
- Univadis Medical News
- 1 comment
Responding to terror attacks: training manual being developed for doctors in Europe
- Univadis Medical News
- 1 comment
Watchdog opens investigation into European Medicines Agency
- Univadis Medical News
- 1 comment
Implementing supported self-management for asthma in UK general practice
Professional & Business
- International Medical Press
Blood donation regulations relaxed for gay men and sex workers
- International Medical Press
NHS England to cut out wasteful drug prescriptions
- International Medical Press
GMC: action plan for revalidation
- International Medical Press
£325 million to ‘modernise and transform’ patient care
- International Medical Press
Government publishes plan for ‘smokefree generation’
- International Medical Press
Declare Suicide Act illegal, high court told
New in Pharmacists
- Univadis Medical News
- 1 comment
EMA suspends authorisation for 3 MRI contrast agents
European Medicines Agency restricts the use of linear gadolinium agents in body scans.
- Clinical Essentials from Lancet Haematol
- 1 comment
Follicular lymphoma: phase 3 trial confirms viability of rituximab biosimilar
More than 9 in 10 patients responded in both treatment arms.
- Clinical Essentials from Stroke
- 1 comment
Stroke prevention in Afib: nonvitamin K antagonist oral anticoagulants have the edge
Will results of clinical trials of these agents hold up in routine clinical care?
- The Lancet
- 1 comment
- FULLTEXT
Germany's increasing contribution to global health
Study suggests the need to accept additional responsibilities
- Clinical Essentials from Lancet Psychiatry
- no comment
For first-episode psychosis, second-generation antipsychotics generally equivalent
The authors recommend that the choice of SGA should be based on side-effect profile.
- Clinical Essentials from J Med Virol
- 1 comment
HCV-3: dual-DAA regimens are best
Data from the real-world GECCO cohort study.
- Clinical Essentials from Onco Targets Ther
- 1 comment
- FULLTEXT
Advanced breast cancer: first-line bevacizumab best with taxane-based chemotherapy
Results of a meta-analysis should settle the debate over how to use bevacizumab.
- Clinical Essentials from Ann Oncol
- 1 comment
Blood test detects EGFR when genetic test isn’t possible
Genetic testing isn’t possible in up to 20% of patients.
- Conference reports - RSi Communications
- 1 comment
Adductor canal nerve blockade equivalent to FNB blockade for pain control after ACL reconstruction | AOSSM
Quadriceps muscle activation deficits were lower for the ACB group at all timepoints.
- Conference reports - RSi Communications
- no comment
Autologous conditioned plasma is first-line option for plantar fasciitis | AOSSM
ACP may optimize healing environment for tissue regeneration and repair.
- Monthly Essentials
- 1 comment
Digestive Disease: Monthly Essentials July 2017
PPIs are linked to increased mortality risk | In pediatric eosinophilic esophagitis nonresponders, check for allergy | GERD may be a sign to look for sleep apnea.
- Clinical Essentials from BMJ
- 1 comment
- FULLTEXT
Antidepressants during pregnancy linked to increase in autism risk
Best designed study to date finds 50% increased risk but the absolute risk is small.
- Clinical Essentials from Arthritis Res Ther
- 1 comment
- FULLTEXT
Obese axial spondyloarthritis patients less likely to respond to TNFis
Yet the drugs are often continued inappropriately.
- Clinical Essentials from FDA
- 1 comment
- FULLTEXT
HCV: FDA greenlights triple-DAA salvage therapy
Second-line pangenotypic SOF/VEL/VOX approved for patients with mild/no cirrhosis.